Tower Research Capital LLC (Trc) Keros Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 22,984 shares of KROS stock, worth $237,194. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,984
Previous 1,839 1149.81%
Holding current value
$237,194
Previous $106,000 242.45%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$15.64 - $70.0 $330,707 - $1.48 Million
21,145 Added 1149.81%
22,984 $363,000
Q3 2024

Nov 14, 2024
SELL
$41.68 - $58.07 $128,541 - $179,087
-3,084 Reduced 62.64%
1,839 $106,000
Q2 2024

Aug 13, 2024
BUY
$44.58 - $66.89 $179,568 - $269,432
4,028 Added 450.06%
4,923 $224,000
Q1 2024

May 15, 2024
SELL
$41.26 - $70.48 $303,962 - $519,226
-7,367 Reduced 89.17%
895 $59,000
Q4 2023

Feb 13, 2024
BUY
$27.12 - $41.05 $206,790 - $313,006
7,625 Added 1197.02%
8,262 $328,000
Q3 2023

Nov 14, 2023
SELL
$31.57 - $43.02 $41,956 - $57,173
-1,329 Reduced 67.6%
637 $20,000
Q2 2023

Aug 14, 2023
BUY
$37.26 - $51.01 $30,776 - $42,134
826 Added 72.46%
1,966 $78,000
Q1 2023

May 09, 2023
BUY
$41.44 - $59.32 $27,101 - $38,795
654 Added 134.57%
1,140 $48,000
Q4 2022

Feb 10, 2023
SELL
$39.45 - $51.77 $92,983 - $122,021
-2,357 Reduced 82.91%
486 $23,000
Q3 2022

Nov 10, 2022
SELL
$27.8 - $40.12 $21,934 - $31,654
-789 Reduced 21.72%
2,843 $107,000
Q2 2022

Aug 15, 2022
BUY
$26.03 - $67.04 $84,727 - $218,215
3,255 Added 863.4%
3,632 $100,000
Q1 2022

May 12, 2022
SELL
$42.12 - $59.36 $54,756 - $77,168
-1,300 Reduced 77.52%
377 $21,000
Q4 2021

Feb 14, 2022
BUY
$36.95 - $62.89 $44,081 - $75,027
1,193 Added 246.49%
1,677 $98,000
Q3 2021

Nov 15, 2021
SELL
$29.27 - $43.71 $15,396 - $22,991
-526 Reduced 52.08%
484 $19,000
Q2 2021

Aug 16, 2021
BUY
$42.4 - $70.11 $18,995 - $31,409
448 Added 79.72%
1,010 $43,000
Q1 2021

May 17, 2021
BUY
$54.0 - $75.28 $19,980 - $27,853
370 Added 192.71%
562 $35,000
Q4 2020

Feb 16, 2021
SELL
$36.0 - $82.74 $223,452 - $513,567
-6,207 Reduced 97.0%
192 $14,000
Q3 2020

Nov 16, 2020
BUY
$27.04 - $62.21 $163,646 - $376,494
6,052 Added 1744.09%
6,399 $247,000
Q2 2020

Aug 13, 2020
BUY
$20.08 - $40.39 $6,967 - $14,015
347 New
347 $13,000

Others Institutions Holding KROS

# of Institutions
172
Shares Held
29.9M
Call Options Held
341K
Put Options Held
102K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $266M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email